Published in Am J Physiol Heart Circ Physiol on September 04, 2009
Arterial aging--hemodynamic changes and therapeutic options. Nat Rev Cardiol (2010) 1.24
Losartan abolishes oxidative stress induced by intermittent hypoxia in humans. J Physiol (2011) 0.80
Increased stiffness and cell-matrix interactions of abdominal aorta in two experimental nonhypertensive models: long-term chemically sympathectomized and sinoaortic denervated rats. J Hypertens (2014) 0.79
miR-181b regulates vascular stiffness age dependently in part by regulating TGF-β signaling. PLoS One (2017) 0.75
Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J (2010) 4.69
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol (2005) 4.20
Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension (2005) 4.08
Salt in health and disease--a delicate balance. N Engl J Med (2013) 3.49
Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation (2012) 3.14
Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension (2007) 2.94
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
Role of pulse pressure amplification in arterial hypertension: experts' opinion and review of the data. Hypertension (2009) 2.58
Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol (2010) 2.54
Obesity is associated with increased arterial stiffness from adolescence until old age. J Hypertens (2005) 2.47
Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens (2002) 2.35
Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol (2004) 2.31
Aortic pulse wave velocity index and mortality in end-stage renal disease. Kidney Int (2003) 2.21
Treating hypertension - what are we to believe? N Engl J Med (2003) 2.10
Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension (2005) 2.08
Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens (2011) 1.89
Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension (2011) 1.84
Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation (2008) 1.82
Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol (2009) 1.79
Aortic pulse wave velocity in renal transplant patients. Kidney Int (2004) 1.67
Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock. Intensive Care Med (2007) 1.67
Short sleep duration and increased risk of hypertension: a primary care medicine investigation. J Hypertens (2012) 1.62
Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress. Crit Care Med (2009) 1.61
Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens (2007) 1.61
Left-ventricular hypertrophy is associated better with 24-h aortic pressure than 24-h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens (2014) 1.51
Aortic stiffness, living donors, and renal transplantation. Hypertension (2006) 1.50
Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients. J Clin Hypertens (Greenwich) (2015) 1.47
Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects. Curr Opin Lipidol (2012) 1.47
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs. Hypertens Res (2011) 1.47
Modifications of arterial phenotype in response to amine oxidase inhibition by semicarbazide. Hypertension (2007) 1.45
Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension (2007) 1.45
Who is fooling us? Lancet (2002) 1.39
The combined effect of aortic stiffness and pressure wave reflections on mortality in the very old with cardiovascular disease: the PROTEGER Study. Hypertens Res (2011) 1.38
Chronic oxidative stress induces a tissue-specific reduction in telomere length in CAST/Ei mice. Free Radic Biol Med (2008) 1.34
Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol (2004) 1.33
Genetics and pathophysiology of arterial stiffness. Cardiovasc Res (2008) 1.28
Influence of lifestyle modification on arterial stiffness and wave reflections. Am J Hypertens (2005) 1.26
Salt loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol (2006) 1.22
Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens (2010) 1.21
Echocardiographic measurement of cardiac output in rats. Am J Physiol Heart Circ Physiol (2002) 1.17
AT1 receptor antagonism attenuates target organ effects of salt excess in SHRs without affecting pressure. Am J Physiol Heart Circ Physiol (2007) 1.15
Sex difference in cardiovascular risk: role of pulse pressure amplification. J Am Coll Cardiol (2012) 1.15
The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature. Vasc Med (2010) 1.14
Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med (2010) 1.12
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin North Am (2004) 1.12
Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension (2011) 1.11
Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens (2004) 1.10
Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens (2007) 1.09
From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy. J Hypertens (2008) 1.09
Sex differences and arterial stiffness: Die Methode ist Alles. J Am Coll Cardiol (2013) 1.09
Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med (2005) 1.08
A translational approach to hypertensive heart disease. Hypertension (2009) 1.07
Resistant hypertension and central aortic pressure. J Hypertens (2014) 1.07
Diastolic dysfunction in hypertension. Curr Opin Cardiol (2002) 1.07
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation (2010) 1.07
Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr Opin Nephrol Hypertens (2002) 1.06
Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuff-based oscillometric device. Am J Hypertens (2012) 1.06
Blood pressure measurement: retrospective and prospective views. Am J Hypertens (2011) 1.06
Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study. Thromb Res (2012) 1.05
Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses. Hypertension (2003) 1.04
Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol (2008) 1.04
Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models. J Am Coll Cardiol (2003) 1.03
Hypertension and depression: coexisting barriers to medication adherence. J Clin Hypertens (Greenwich) (2010) 1.02
Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol (2005) 1.02
Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol (2007) 1.00
Medication adherence in older clinic patients with hypertension after Hurricane Katrina: implications for clinical practice and disaster management. Am J Med Sci (2008) 0.99
Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens (2002) 0.99
Salt-induced renal injury in SHRs is mediated by AT1 receptor activation. J Hypertens (2011) 0.98
Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). J Hypertens (2015) 0.97
Central hemodynamic modifications in diabetes mellitus. Atherosclerosis (2013) 0.96
Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study. Am J Hypertens (2004) 0.96
Local cardiac renin-angiotensin system: hypertension and cardiac failure. J Mol Cell Cardiol (2002) 0.96
Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol (2005) 0.95
Prevention of hypertension. Curr Opin Cardiol (2002) 0.95
Long-term mineralocorticoid receptor blockade reduces fibrosis and improves cardiac performance and coronary hemodynamics in elderly SHR. Am J Physiol Heart Circ Physiol (2006) 0.95
Aortic stiffness and cardiovascular risk in type 2 diabetes. J Hypertens (2013) 0.95
Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens (2007) 0.95
Cardiovascular effects of prorenin blockade in genetically spontaneously hypertensive rats on normal and high-salt diet. Am J Physiol Heart Circ Physiol (2008) 0.95
N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAME/SHR model. J Hypertens (2002) 0.94
Cardiac structural and functional responses to salt loading in SHR. Am J Physiol Heart Circ Physiol (2004) 0.94
Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality. J Hypertens (2008) 0.93
Characteristics of pulse wave velocity in elastic and muscular arteries: a mismatch beyond age. J Hypertens (2013) 0.93
Gender influence on metabolic syndrome's effects on arterial stiffness and pressure wave reflections in treated hypertensive subjects. Atherosclerosis (2006) 0.92
On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides (2011) 0.91
Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone. J Renin Angiotensin Aldosterone Syst (2006) 0.91
Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension (2005) 0.90
Hypertensive Cardiovascular and Renal Disease and Target Organ Damage: Lessons from Animal Models. Cardiorenal Med (2011) 0.90
Microvascular dysfunction in healthy insulin-sensitive overweight individuals. J Hypertens (2010) 0.90
Crosslink breakers: a new approach to cardiovascular therapy. Curr Opin Cardiol (2004) 0.90
Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure. J Mol Cell Cardiol (2005) 0.89
Macrovascular and microvascular dysfunction in the metabolic syndrome. Hypertens Res (2010) 0.89
The aging hypertensive heart: a brief update. Nat Clin Pract Cardiovasc Med (2008) 0.88
Cardiovascular effects of nonproteolytic activation of prorenin. Hypertension (2006) 0.88
Selective reduction of central pulse pressure under angiotensin blockage in SHR: role of the fibronectin-alpha5beta1 integrin complex. Am J Hypertens (2009) 0.88
Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. Br J Haematol (2007) 0.88
Differences in central systolic blood pressure and aortic stiffness between aerobically trained and sedentary individuals. J Am Soc Hypertens (2011) 0.88
Aortic wave reflection in women and men. Am J Physiol Heart Circ Physiol (2010) 0.87
Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens (2007) 0.87